We are live on ! Find out more
HAG

HighPoint Advisor Group Portfolio holdings

AUM $2.84B
1-Year Est. Return 31.94%
This Fund
S&P 500
This Quarter Est. Return
-11.2%
1 Year Est. Return
+31.94%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$378M
AUM Growth
+$12.4M
Cap. Flow
+$1.24B
Cap. Flow %
329.23%
Top 10 Hldgs %
27%
Holding
388
New
36
Increased
167
Reduced
112
Closed
67

Top Buys

Rank Stock Value
1
BRK.A icon
Berkshire Hathaway Class A
BRK.A
+$1.22B
2
V icon
Visa
V
+$10.5M
3
WMT icon
Walmart Inc
WMT
+$6.77M
4
AAPL icon
Apple
AAPL
+$5.34M
5
COKE icon
Coca-Cola Consolidated
COKE
+$4.47M

Sector Composition

Rank Sector Weight
1 Technology 15.02%
2 Consumer Staples 13.47%
3 Healthcare 12.42%
4 Financials 12.33%
5 Industrials 10.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HPE icon
251
Hewlett Packard
HPE
$70.5B
$244K 0.06%
+15,184
New +$227K
ORLY icon
252
O'Reilly Automotive
ORLY
$76.3B
$244K 0.06%
9,540
+1,605
+20% +$36.5K
AGN
253
DELISTED
Allergan plc
AGN
$244K 0.06%
1,774
+125
+8% +$20.5K
AMP icon
254
Ameriprise Financial
AMP
$48.8B
$242K 0.06%
1,859
-435
-19% -$54.6K
SYK icon
255
Stryker
SYK
$130B
$242K 0.06%
+1,301
New +$218K
DGX icon
256
Quest Diagnostics
DGX
$26.3B
$240K 0.06%
2,727
+734
+37% +$68.8K
ZTS icon
257
Zoetis
ZTS
$30B
$240K 0.06%
2,532
+81
+3% +$7.29K
CMI icon
258
Cummins
CMI
$88.7B
$238K 0.06%
1,553
-205
-12% -$28.9K
MAR icon
259
Marriott International
MAR
$92.3B
$231K 0.06%
1,900
-840
-31% -$96.4K
BNY
260
Bank of New York Mellon
BNY
$107B
$229K 0.06%
4,339
+285
+7% +$13.8K
STT icon
261
State Street
STT
$50.7B
$228K 0.06%
3,207
+69
+2% +$4.94K
AZN icon
262
AstraZeneca
AZN
$250B
$227K 0.06%
2,810
-800
-22% -$62.5K
CBRL icon
263
Cracker Barrel
CBRL
$1.29B
$227K 0.06%
1,322
-53
-4% -$8.71K
ETR icon
264
Entergy
ETR
$50B
$226K 0.06%
5,030
+72
+1% +$3.06K
ONCE
265
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$224K 0.06%
4,390
-2,300
-34% -$99.8K
CTSH icon
266
Cognizant
CTSH
$26B
$217K 0.06%
2,970
+506
+21% +$35.2K
KR icon
267
Kroger
KR
$34.8B
$215K 0.06%
7,290
-265
-4% -$7.69K
TEVA icon
268
Teva Pharmaceuticals
TEVA
$41.2B
$214K 0.06%
11,885
+1,153
+11% +$23.6K
BTI icon
269
British American Tobacco
BTI
$128B
$213K 0.06%
+5,836
New +$227K
TAK icon
270
Takeda Pharmaceutical
TAK
$55.7B
$213K 0.06%
+10,563
New +$178K
ALLY icon
271
Ally Financial
ALLY
$13.3B
$211K 0.06%
+7,783
New +$195K
CVIA
272
DELISTED
Covia Holdings Corporation Common Stock
CVIA
$209K 0.06%
42,089
+9,999
+31% +$60.2K
DG icon
273
Dollar General
DG
$27.9B
$208K 0.06%
1,751
+176
+11% +$19.1K
FIS icon
274
Fidelity National Information Services
FIS
$22.1B
$208K 0.06%
1,921
+73
+4% +$7.61K
CHL
275
DELISTED
China Mobile Limited
CHL
$206K 0.05%
3,918
-418
-10% -$20.1K

Similar funds

HighPoint Advisor Group's Q4 2018 Portfolio in Review

As of Q4 2018, HighPoint Advisor Group held 388 positions worth $378M, up 3.4% from $365M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

HighPoint Advisor Group deployed $1.24B of net new capital in Q4 2018, opening 36 new positions and adding to 167 existing holdings. Its largest new stake was Xilinx Inc: 48,952 shares worth $932K.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Consumer Staples and Healthcare.

On the sell side, the largest reduction was Walgreens Boots Alliance, an estimated $8.31M trimmed.

  • HighPoint Advisor Group's largest Q4 2018 buy was Xilinx Inc: 48,952 shares worth $932K.
  • HighPoint Advisor Group added most to Berkshire Hathaway Class A in Q4 2018, an estimated $1.22B increase.
  • HighPoint Advisor Group's biggest Q4 2018 reduction was Walgreens Boots Alliance, cutting an estimated $8.31M.
  • HighPoint Advisor Group fully exited Corporate Capital Trust, Inc. in Q4 2018, selling an estimated $2.39M.
  • HighPoint Advisor Group's ten largest holdings make up 27% of its $378M portfolio in Q4 2018.
  • HighPoint Advisor Group opened 36 new positions and closed 67 in Q4 2018.
  • HighPoint Advisor Group's portfolio value rose 3.4% quarter-over-quarter to $378M.

Based on HighPoint Advisor Group's 13F filing for Q4 2018, filed 20 Feb 2019.